Kytopen Company
Kytopen developer of a cell therapy platform for non-viral delivery of molecules into hard-to-transfect immune cells.
Connections from
Funding Status:
Early Stage Venture
Total Funding:
36095000
Last Funding Type:
Series A
Industry:
Gene therapy
Founded Date:
1/1/2017
Headquarters:
Cambridge, Massachusetts, United States
Employee Number:
11-50